1. Home
  2. NBHC vs NRIX Comparison

NBHC vs NRIX Comparison

Compare NBHC & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NBHC

National Bank Holdings Corporation

N/A

Current Price

$39.65

Market Cap

1.6B

Sector

Finance

ML Signal

N/A

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

N/A

Current Price

$15.85

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NBHC
NRIX
Founded
2009
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
NBHC
NRIX
Price
$39.65
$15.85
Analyst Decision
Buy
Strong Buy
Analyst Count
3
13
Target Price
$45.33
$29.46
AVG Volume (30 Days)
464.5K
694.1K
Earning Date
04-28-2026
05-01-2026
Dividend Yield
3.19%
N/A
EPS Growth
N/A
N/A
EPS
2.85
N/A
Revenue
$47,100,000.00
$76,987,000.00
Revenue This Year
$39.32
N/A
Revenue Next Year
$6.74
$26.32
P/E Ratio
$14.11
N/A
Revenue Growth
2.86
99.31
52 Week Low
$32.83
$8.18
52 Week High
$42.99
$22.50

Technical Indicators

Market Signals
Indicator
NBHC
NRIX
Relative Strength Index (RSI) 42.30 46.92
Support Level $37.79 $15.62
Resistance Level $40.97 $16.49
Average True Range (ATR) 1.13 0.78
MACD -0.19 0.05
Stochastic Oscillator 19.01 65.87

Price Performance

Historical Comparison
NBHC
NRIX

About NBHC National Bank Holdings Corporation

National Bank Holdings Corp is a bank holding company. It provides various banking products and financial services to commercial, business, and consumer clients in the United States. The company offers deposit products including checking accounts, savings accounts, money market accounts, and other deposit accounts, including fixed-rate and fixed-maturity time deposits. It also provides commercial and industrial loans and leases. In addition, it offers treasury management solutions comprising online and mobile banking, commercial credit cards, wire transfers, automated clearing house, and electronic bill payments.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.

Share on Social Networks: